SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sabina Berezowska, Michael J Flaig, Franziska Ruëff, Christoph Walz, Torsten Haferlach, Manuela Krokowski, Roswitha Kerler, Karina Petat-Dutter, Hans-Peter Horny, Karl Sotlar, Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis, Modern Pathology, 2014, 27, 1, 19

    CrossRef

  2. 2
    A. Matito, I. Alvarez-Twose, J. M. Morgado, L. Sánchez-Muñoz, A. Orfao, L. Escribano, Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders, Current Allergy and Asthma Reports, 2014, 14, 8

    CrossRef

  3. 3
    Timothy B. Oriss, Nandini Krishnamoorthy, Prabir Ray, Anuradha Ray, Dendritic cell c-kit signaling and adaptive immunity, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 1, 7

    CrossRef

  4. 4
    Sophie Georgin-Lavialle, Daniela Silva Moura, Julie Bruneau, Jean-Christophe Chauvet-Gélinier, Gandhi Damaj, Erinn Soucie, Stéphane Barete, Anne-Laure Gacon, Catherine Grandpeix-Guyodo, Felipe Suarez, Jean-Marie Launay, Isabelle Durieu, Aurélie Esparcieux, Isabelle Guichard, Agnès Sparsa, Franck Nicolini, Christian de Gennes, Benoit Trojak, Emmanuel Haffen, Pierre Vandel, Olivier Lortholary, Patrice Dubreuil, Bernard Bonin, Serge Sultan, Jean-Raymond Teyssier, Olivier Hermine, Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress, Brain, Behavior, and Immunity, 2014, 35, 51

    CrossRef

  5. 5
    Iván Alvarez-Twose, Almudena Matito, Laura Sánchez-Muñoz, José Mário Morgado, Luis Escribano, Management of adult mastocytosis, Expert Opinion on Orphan Drugs, 2014, 2, 4, 321

    CrossRef

  6. 6
    Ilaria Marech, Rosa Patruno, Nicola Zizzo, Claudia Gadaleta, Marcello Introna, Alfredo Francesco Zito, Cosmo Damiano Gadaleta, Girolamo Ranieri, Masitinib (AB1010), from canine tumor model to human clinical development: Where we are?, Critical Reviews in Oncology/Hematology, 2014, 91, 1, 98

    CrossRef

  7. 7
    Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink, Receptors, cells and circuits involved in pruritus of systemic disorders, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 7, 869

    CrossRef

  8. You have free access to this content8
    Srdan Verstovsek, Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression, European Journal of Haematology, 2013, 90, 2
  9. 9
    N. Arase, M. Wataya-Kaneda, N. Oiso, H. Arase, I. Katayama, CD1a-positive familial cutaneous mastocytosis without germ-line or somatic mutations in c-kit, British Journal of Dermatology, 2013, 169, 1
  10. 10
    Eszter Rausz, Agnes Szilágyi, Boguslaw Nedoszytko, Magdalena Lange, Marek Niedoszytko, Orsolya Lautner-Csorba, András Falus, István Aladzsity, Márta Kokai, Peter Valent, Márta Marschalko, Bernadett Hidvégi, József Szakonyi, Judit Csomor, Judit Várkonyi, Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis, British Journal of Haematology, 2013, 160, 2
  11. 11
    J. Schwaab, S. Schnittger, K. Sotlar, C. Walz, A. Fabarius, M. Pfirrmann, A. Kohlmann, V. Grossmann, M. Meggendorfer, H.-P. Horny, P. Valent, M. Jawhar, M. Teichmann, G. Metzgeroth, P. Erben, T. Ernst, A. Hochhaus, T. Haferlach, W.-K. Hofmann, N. C. P. Cross, A. Reiter, Comprehensive mutational profiling in advanced systemic mastocytosis, Blood, 2013, 122, 14, 2460

    CrossRef

  12. 12
    Nicole M. Fett, Joyce Teng, B. Jack Longley, Familial Urticaria Pigmentosa, The American Journal of Dermatopathology, 2013, 35, 1, 113

    CrossRef

  13. 13
    Young S. Kim, Huiqing Wu, Anna B. Pawlowska, Marnelli A. Bautista-Quach, Qin Huang, Karl Gaal, Karen L. Chang, Pediatric Mast Cell Sarcoma of Temporal Bone With Novel L799F (2395 C>T) KIT Mutation, Mimicking Histiocytic Neoplasm, The American Journal of Surgical Pathology, 2013, 37, 3, 453

    CrossRef

  14. 14
    Roberta Zanotti, Livio Simioni, Andres C. Garcia-Montero, Omar Perbellini, Patrizia Bonadonna, Beatrice Caruso, Maria Jara-Acevedo, Massimiliano Bonifacio, Giovanna De Matteis, Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis, Journal of Allergy and Clinical Immunology, 2013, 131, 2, 605

    CrossRef

  15. 15
    Bérengère Gruson, Olivier Lortholary, Danielle Canioni, Olivia Chandesris, Fanny Lanternier, Julie Bruneau, Bernard Grosbois, Cristina Livideanu, Claire Larroche, Isabelle Durieu, Stéphane Barete, Henri Sevestre, Momar Diouf, Guillaume Chaby, Jean-Pierre Marolleau, Patrice Dubreuil, Olivier Hermine, Gandhi Damaj, Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study, British Journal of Haematology, 2013, 161, 3
  16. 16
    J Sun, S Mohlin, A Lundby, J U Kazi, U Hellman, S Påhlman, J V Olsen, L Rönnstrand, The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner, Oncogene, 2013,

    CrossRef

  17. 17
    Leonie K Ashman, Renate Griffith, Therapeutic targeting of c-KIT in cancer, Expert Opinion on Investigational Drugs, 2013, 22, 1, 103

    CrossRef

  18. 18
    C Teodosio, A C García-Montero, M Jara-Acevedo, I Álvarez-Twose, L Sánchez-Muñoz, J Almeida, J M Morgado, A Matito, L Escribano, A Orfao, An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis, Leukemia, 2012, 26, 5, 951

    CrossRef

  19. 19
    Odile Malbec, Marc Daëron, Antibodies against growth factor receptors can inhibit the proliferation of transformed cells via a cis-interaction with inhibitory FcR, Immunology Letters, 2012, 143, 1, 28

    CrossRef

  20. 20
    Antonio Torrelo, Iván Alvarez-Twose, Luis Escribano, Childhood mastocytosis, Current Opinion in Pediatrics, 2012, 1

    CrossRef

  21. 21
    Thomas Kristensen, Sigurd Broesby-Olsen, Hanne Vestergaard, Carsten Bindslev-Jensen, Michael B. Møller, Circulating KITD816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis, European Journal of Haematology, 2012, 89, 1
  22. 22
    I. ALVAREZ-TWOSE, J. M. MORGADO, L. SÁNCHEZ-MUÑOZ, A. GARCÍA-MONTERO, M. MOLLEJO, A. ORFAO, L. ESCRIBANO, Current state of biology and diagnosis of clonal mast cell diseases in adults, International Journal of Laboratory Hematology, 2012, 34, 5
  23. 23
    M. Lange, M. Niedoszytko, B. Nedoszytko, J. Łata, M. Trzeciak, W. Biernat, Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 12
  24. 24
    Olivera Casar-Borota, Stine Lyngvi Fougner, Jens Bollerslev, Jahn Marthin Nesland, KIT protein expression and mutational status of KIT gene in pituitary adenomas, Virchows Archiv, 2012, 460, 2, 171

    CrossRef

  25. 25
    Lijuan He, Kalina Hristova, Physical–chemical principles underlying RTK activation, and their implications for human disease, Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012, 1818, 4, 995

    CrossRef

  26. 26
    C Möller Westerberg, H Hägglund, G Nilsson, Proteasome inhibition upregulates Bim and induces caspase-3-dependent apoptosis in human mast cells expressing the Kit D816V mutation, Cell Death and Disease, 2012, 3, 11, e417

    CrossRef

  27. 27
    Britta Haenisch, Markus M. Nöthen, Gerhard J. Molderings, Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics, Immunology, 2012, 137, 3
  28. 28
    Maggie M. Stoecker, Endi Wang, Systemic Mastocytosis With Associated Clonal Hematologic Nonmast Cell Lineage Disease: A Clinicopathologic Review, Archives of Pathology & Laboratory Medicine, 2012, 136, 7, 832

    CrossRef

  29. 29
    Alberto Álvarez-Larrán, Jordi Rimola, Francisco Lomeña, María Rozman, Varón de 67 años con dolor abdominal, esplenomegalia, adenopatías y alteraciones de la densidad ósea, Medicina Clínica, 2012, 139, 7, 300

    CrossRef

  30. 30
    Klinische Immunologie, 2012,

    CrossRef

  31. 31
    Shakil H. Merchant, Jennifer L. Oliveira, James D. Hoyer, David S. Viswanatha, Hematopathology, 2012,

    CrossRef

  32. 32
    Andrzej Mital, Anna Piskorz, Krzysztof Lewandowski, Bartosz Wasąg, Janusz Limon, Andrzej Hellmann, A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib, European Journal of Haematology, 2011, 86, 6
  33. 33
    Jae-Hwan Kim, Tao Zhong, In-Cheol Cho, Hyun-Tae Lim, Chae-Kyoung Yoo, Byeong-Woo Kim, Jun-Heon Lee, Jin-Tae Jeon, Characterization of an alternative splicing by a NAGNAG splice acceptor site in the porcine KIT gene, Genes & Genomics, 2011, 33, 2, 179

    CrossRef

  34. You have full text access to this OnlineOpen article34
    Fabio Bozzi, Elena Conca, Giacomo Manenti, Tiziana Negri, Silvia Brich, Alessandro Gronchi, Marco A. Pierotti, Elena Tamborini, Silvana Pilotti, High CD133 expression levels in gastrointestinal stromal tumors, Cytometry Part B: Clinical Cytometry, 2011, 80B, 4
  35. 35
    Thomas Kristensen, Hanne Vestergaard, Michael Boe Møller, Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay, The Journal of Molecular Diagnostics, 2011, 13, 2, 180

    CrossRef

  36. 36
    Gerhard J Molderings, Stefan Brettner, Jürgen Homann, Lawrence B Afrin, Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options, Journal of Hematology & Oncology, 2011, 4, 1, 10

    CrossRef

  37. 37
    T. A. Rama, I. Côrte-Real, P. S. Gomes, L. Escribano, M. H. Fernandes, Mastocytosis: oral implications of a rare disease, Journal of Oral Pathology & Medicine, 2011, 40, 6
  38. 38
    David González-de-Olano, Iván Álvarez-Twose, Arantza Vega, Alberto Orfao, Luis Escribano, Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis, Immunotherapy, 2011, 3, 5, 637

    CrossRef

  39. 39
    David R. Czuchlewski, David S. Viswanatha, Richard S. Larson, Henry's Clinical Diagnosis and Management by Laboratory Methods, 2011,

    CrossRef

  40. 40
    Laura Sánchez-Muñoz, Cristina Teodósio, José M. Morgado, Luis Escribano, Recent Advances in Cytometry, Part B - Advances in Applications, 2011,

    CrossRef

  41. 41
    Jean-Emmanuel Kurtz, Irène Asmane, Anne-Claire Voegeli, Agnès Neuville, Armelle Dufresne, Valère Litique, Christine Chevreau, Jean-Pierre Bergerat, A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis, Sarcoma, 2010, 2010, 1

    CrossRef

  42. 42
    BaoJin Wu, LiJing Yin, ZhengLan Lu, YuShu Yin, WeiWei Yang, Rong Yang, XiaoDong Kang, GuiJie Liu, HongPing Yin, LiPing Yu, MeiEr Gu, PeiLin Wu, Abnormal gonad development in Kit W-2Bao mice caused by a Kit gene missense mutation, Chinese Science Bulletin, 2010, 55, 36, 4143

    CrossRef

  43. 43
    J Rocha, M Luz Duarte, H Marques, F Torres, P Tavares, A Silva, C Brito, Association of adult mastocytosis with M541L in the transmembrane domain of KIT, Journal of the European Academy of Dermatology and Venereology, 2010, 24, 9
  44. 44
    Irene Ruano, Ricardo Gargini, Marta Izquierdo, Combination of KIT gene silencing and tocopherol succinate may offer improved therapeutic approaches for human mastocytosis, British Journal of Haematology, 2010, 148, 1
  45. 45
    Gerhard J. Molderings, Kirsten Meis, Ulrich W. Kolck, Jürgen Homann, Thomas Frieling, Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects, Immunogenetics, 2010, 62, 11-12, 721

    CrossRef

  46. 46
    Julie A. Smith, Lionel A. Samayawardhena, Andrew W.B. Craig, Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and β1 integrin receptors, Cellular Signalling, 2010, 22, 3, 427

    CrossRef

  47. You have full text access to this OnlineOpen article47
    Carle Paul, Beatrix Sans, Felipe Suarez, Philippe Casassus, Stéphane Barete, Fanny Lanternier, Catherine Grandpeix-Guyodo, Patrice Dubreuil, Fabienne Palmérini, Colin D. Mansfield, Paul Gineste, Alain Moussy, Olivier Hermine, Olivier Lortholary, Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study, American Journal of Hematology, 2010, 85, 12
  48. 48
    Cristina Teodosio, Andrés C. García-Montero, María Jara-Acevedo, Laura Sánchez-Muñoz, Ivan Álvarez-Twose, Rosa Núñez, Lawrence B. Schwartz, Andrew F. Walls, Luis Escribano, Alberto Orfao, Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes, Journal of Allergy and Clinical Immunology, 2010, 125, 3, 719

    CrossRef

  49. You have free access to this content49
    Ulrich Amon, Karin Hartmann, Hans-Peter Horny, Anna Nowak, Mastocytosis – an update, JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2010, 8, 9
  50. 50
    Mayu Isotani, Osamu Yamada, Joshua L. Lachowicz, Kyoichi Tamura, Hiroko Yagihara, Yasuhito Fujino, Kenichiro Ono, Tsukimi Washizu, Makoto Bonkobara, Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours, British Journal of Haematology, 2010, 148, 1
  51. 51
    Michel Arock, Peter Valent, Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives, Expert Review of Hematology, 2010, 3, 4, 497

    CrossRef

  52. 52
    Akane Tsujimura, Hitoshi Kiyoi, Yukimasa Shiotsu, Yuichi Ishikawa, Yumiko Mori, Hiroshi Ishida, Tsutomu Toki, Etsuro Ito, Tomoki Naoe, Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia, International Journal of Hematology, 2010, 92, 4, 624

    CrossRef

  53. 53
    Prabir Ray, Nandini Krishnamoorthy, Timothy B. Oriss, Anuradha Ray, Signaling of c-kit in dendritic cells influences adaptive immunity, Annals of the New York Academy of Sciences, 2010, 1183, 1
  54. 54
    Scott E. Woodman, Michael A. Davies, Targeting KIT in melanoma: A paradigm of molecular medicine and targeted therapeutics, Biochemical Pharmacology, 2010, 80, 5, 568

    CrossRef

  55. 55
    Yoshihide Asano, Andreea M. Bujor, Maria Trojanowska, The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis, Journal of Dermatological Science, 2010, 59, 3, 153

    CrossRef

  56. 56
    W. Glenn McCluggage, N. Engin Aydin, Newton A. C. S. Wong, Kumarasen Cooper, Low-grade Epithelial-Myoepithelial Carcinoma of Bartholin Gland: Report of 2 Cases of a Distinctive Neoplasm Arising in the Vulvovaginal Region, International Journal of Gynecological Pathology, 2009, 28, 3, 286

    CrossRef

  57. 57
    Dragan Jevremovic, David S. Viswanatha, Molecular Diagnosis of Hematopoietic and Lymphoid Neoplasms, Hematology/Oncology Clinics of North America, 2009, 23, 4, 903

    CrossRef

  58. 58
    Zhuang Zuo, Pranil Chandra, Yong Hannah Wen, Hartmut Koeppen, Molecular diagnostics of acute myeloid leukaemia, Diagnostic Histopathology, 2009, 15, 11, 531

    CrossRef

  59. 59
    April Chiu, Nahid M Nanaji, Magdalena Czader, Gabriela Gheorghe, Daniel M Knowles, Amy Chadburn, Attilio Orazi, The stromal composition of mast cell aggregates in systemic mastocytosis, Modern Pathology, 2009, 22, 7, 857

    CrossRef

  60. 60
    Yuval Bibi, Alice B. Gottlieb, A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis, Journal of the American Academy of Dermatology, 2008, 59, 4, 654

    CrossRef

  61. 61
    Valeska Heib, Marc Becker, Christian Taube, Michael Stassen, Advances in the understanding of mast cell function, British Journal of Haematology, 2008, 142, 5
  62. 62
    R. Foster, E. Byrnes, C. Meldrum, R. Griffith, G. Ross, E. Upjohn, A. Braue, R. Scott, G. Varigos, P. Ferrao, L.K. Ashman, Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT, British Journal of Dermatology, 2008, 159, 5
  63. 63
    Y. Yamada, A. Sanchez-Aguilera, E. B. Brandt, M. McBride, N. J. H. Al-Moamen, F. D. Finkelman, D. A. Williams, J. A. Cancelas, M. E. Rothenberg, FIP1L1/PDGFR  synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome, Blood, 2008, 112, 6, 2500

    CrossRef

  64. 64
    Claudiu V. Cotta, Raymond R. Tubbs, Mutations in Myeloid Neoplasms, Diagnostic Molecular Pathology, 2008, 17, 4, 191

    CrossRef

  65. 65
    K. M. Hoffmann, A. Moser, P. Lohse, A. Winkler, B. Binder, P. Sovinz, H. Lackner, W. Schwinger, M. Benesch, C. Urban, Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation, Blood, 2008, 112, 5, 1655

    CrossRef

  66. 66
    Grace K. Dy, Alex A. Adjei, Systemic cancer therapy: Evolution over the last 60 years, Cancer, 2008, 113, S7
  67. 67
    Ozden Ozer, Yi D. Zhao, Kelly R. Ostler, Cem Akin, John Anastasi, James W. Vardiman, Lucy A. Godley, The identification and characterisation of novelKITtranscripts in aggressive mast cell malignancies and normal CD34+ cells, Leukemia & Lymphoma, 2008, 49, 8, 1567

    CrossRef

  68. 68
    K. J. Aichberger, W. R. Sperr, K. V. Gleixner, A. Kretschmer, P. Valent, Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis, European Journal of Clinical Investigation, 2008, 38, 11
  69. 69
    Luis Escribano, Andrés Garcia-Montero, Laura Sanchez-Muñoz, Cristina Teodosio, Ivan Alvarez-Twose, Maria Jara-Acevedo, José Mario Morgado, Julia Almeida, Alberto Orfao, Diagnosis of Adult Mastocytosis: Role for Bone Marrow Analysis,
  70. 70
    Dirk Van Gysel, Ron H. N. van Schaik, Arnold P. Oranje, Mastocytosis,